| 초록 |
Background: Reactive oxygen species (ROS) generation, apoptosis, and necrosis play a role in cisplatin induced nephrotoxicity. LG life sciences developed a novel class of small molecule mitochondrial ROS scavenger NecroX series that can reduce reactive oxygen species and necroptosis pathway. We therefore investigated the effect of NecroX-7 on cisplatin nephrotoxicity in mice.
Methods: C57BL/6 mice were divided into 4 groups; normal control group (n=5), NecroX-7 treated control group (n=5), vehicle with cisplatin (15mg/kg, intraperitoneal injection) treated group (n=9), and NecroX-7 (2mg/kg, intraperitoneal injection) with cisplatin treated group (n=9). We measured BUN and serum creatinine. We examined 8-OH deoxyguanosine, RIP1, RIP3, MLKL, and light microscopic findings (H&E and PAS stain).
Results: C57BL/6 mice were divided into 4 groups; normal control group (n=5), NecroX-7 treated control group (n=5), vehicle with cisplatin (15mg/kg, intraperitoneal injection) treated group (n=9), and NecroX-7 (2mg/kg, intraperitoneal injection) with cisplatin treated group (n=9). We measured BUN and serum creatinine. We examined 8-OH deoxyguanosine, RIP1, RIP3, MLKL, and light microscopic findings (H&E and PAS stain).
Conclusion: NecroX-7 attenuates cisplatin induced nephrotoxicity. |